These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27287786)

  • 1. Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia.
    Terzić T; Kastelic M; Dolžan V; Plesničar BK
    Psychiatr Danub; 2016 Jun; 28(2):127-31. PubMed ID: 27287786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.
    Ma L; Zhang X; Xiang Q; Zhou S; Zhao N; Xie Q; Zhao X; Zhou Y; Cui Y
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):94-104. PubMed ID: 30103286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms.
    Srivastava V; Varma PG; Prasad S; Semwal P; Nimgaonkar VL; Lerer B; Deshpande SN; BK T
    Pharmacogenet Genomics; 2006 Feb; 16(2):111-7. PubMed ID: 16424823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.
    Oishi K; Kanahara N; Takase M; Oda Y; Nakata Y; Niitsu T; Ishikawa M; Sato Y; Iyo M
    PLoS One; 2018; 13(11):e0207133. PubMed ID: 30408108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of dopamine receptor genes polymorphisms with the risk of schizophrenia in the Han Chinese population.
    Yang B; Niu W; Chen S; Xu F; Li X; Wu X; Cao Y; Zhang R; Yang F; Wang L; Li W; Xu Y; He L; He G
    Psychiatry Res; 2016 Nov; 245():361-364. PubMed ID: 27591410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs.
    Ota VK; Spíndola LN; Gadelha A; dos Santos Filho AF; Santoro ML; Christofolini DM; Bellucco FT; Ribeiro-dos-Santos ÂK; Santos S; Mari Jde J; Melaragno MI; Bressan RA; Smith Mde A; Belangero SI
    Schizophr Res; 2012 Dec; 142(1-3):206-8. PubMed ID: 23036699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.
    Gupta M; Chauhan C; Bhatnagar P; Gupta S; Grover S; Singh PK; Purushottam M; Mukherjee O; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Feb; 10(2):277-91. PubMed ID: 19207030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment.
    Werner FM; Coveñas R
    Curr Pharm Des; 2021 Oct; 27(30):3281-3292. PubMed ID: 33588721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
    Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
    Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of gene polymorphisms DRD3 rs6280, COMT rs4680 and HTR2A rs7322347 with schizophrenia].
    Sofronov AG; Dobrovolskaya AE; Morozova AY; Gorina EA; Kolchev SA; Gvozdetckii AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):115-120. PubMed ID: 35904302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia.
    Taheri N; Pirboveiri R; Sayyah M; Bijanzadeh M; Ghandil P
    BMC Psychiatry; 2023 Oct; 23(1):781. PubMed ID: 37880658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commonly-occurring polymorphisms in the COMT, DRD1 and DRD2 genes influence different aspects of motor sequence learning in humans.
    Baetu I; Burns NR; Urry K; Barbante GG; Pitcher JB
    Neurobiol Learn Mem; 2015 Nov; 125():176-88. PubMed ID: 26419600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.
    Zakharyan R; Ghazaryan H; Kocourkova L; Chavushyan A; Mkrtchyan A; Zizkova V; Arakelyan A; Petrek M
    Arch Med Res; 2020 Jan; 51(1):13-20. PubMed ID: 32086104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.
    de Matos LP; Santana CV; Souza RP
    Psychiatry Res; 2015 Sep; 229(1-2):586-8. PubMed ID: 26213377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential link between genetic polymorphisms of
    Han J; Li Y; Wang X
    Neuropsychiatr Dis Treat; 2017; 13():2935-2943. PubMed ID: 29255361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
    Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
    Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
    Gunes A; Scordo MG; Jaanson P; Dahl ML
    Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.
    Kukshal P; Kodavali VC; Srivastava V; Wood J; McClain L; Bhatia T; Bhagwat AM; Deshpande SN; Nimgaonkar VL; Thelma BK
    J Psychiatr Res; 2013 Nov; 47(11):1615-22. PubMed ID: 23932573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.